ONCONIX: A revolutionary organoid culturing and drug efficacy testing platform for personalized response prediction to cancer therapies (Innolink: 101

• Unité de recherche: INNOSUISSE
• Numéro de projet: 101.951 IP-LS
• Titre du projet anglais: ONCONIX: A revolutionary organoid culturing and drug efficacy testing platform for personalized response prediction to cancer therapies (Innolink: 101

Mots-clé (Anglais)

Life sciences, Personalised medicine

Résumé des résultats (Abstract) (Anglais)

We will deliver ONCONIX: a highly innovative personalized treatment-response prediction platform for oncology based on uniquely rapid patient-derived organoid cultures and in-house developed machine learning models. Here, we will perform a non-interventional proof-of-concept study in bladder cancer.